5398 篇
13910 篇
478050 篇
16308 篇
11770 篇
3941 篇
6548 篇
1253 篇
75656 篇
37910 篇
12167 篇
1665 篇
2868 篇
3421 篇
641 篇
1241 篇
1980 篇
4921 篇
3875 篇
5491 篇
全球过敏性鼻炎的药物市场报告(2016-2020年)
Global Allergic Rhinitis Drugs Market 2016-2020
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Overview: Allergic rhinitis
Understanding the disease
Classification of allergic rhinitis
Causes
Signs and symptoms
Risk factors
Diagnosis and testing
Treatment
Epidemiology
Economic burden and impact on quality of life
PART 06: Pipeline analysis
Information on pipeline candidates
Clinical trial information of allergic rhinitis
PART 07: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 08: Market segmentation based on class of drugs
Antihistamines
Intranasal corticosteroids
Immunotherapies
Global antihistamines drugs market
Global intranasal corticosteroids drugs market
Global immunotherapies drugs market
PART 09: Market segmentation by route of
administration
Oral
Parenteral
Intranasal
PART 10: Market segmentation by dosage form
Solid
Liquid
PART 11: Geographical segmentation
Global allergic rhinitis drugs market by geography 2015-
2020
Allergic rhinitis drugs market in Americas
Allergic rhinitis drugs market in EMEA
Allergic rhinitis drugs market in APAC
PART 12: Market drivers
Increased prevalence of allergic rhinitis
Rise in awareness about allergic rhinitis
High usage of tobacco
Presence of high unmet medical needs
PART 13: Impact of drivers
PART 14: Market challenges
Increased preference for CAM
Patent expiries and competition from generic drugs
Adverse effects of drugs
Poor patient adherence
PART 15: Impact of drivers and challenges
PART 16: Market trends
Self-medication using OTC products
Increased R&D
Intense competition
Strategic alliances
PART 17: Vendor landscape
Competitive scenario
Market share analysis 2015
AstraZeneca
GlaxoSmithKline
Meda Pharmaceuticals
Merck
Sanofi
UCB
Other prominent vendors
PART 18: Appendix
List of abbreviations
PART 19: Explore Technavio